Evogliptin 5mg

DRUG5 trials

Sponsors

Dong-A ST Co., Ltd., Seung Up Kim

Conditions

Diabetes Mellitus, Type 2Fibrosis, LiverHemodialysis PatientsHepatitis B, ChronicType 2 DiabetesType 2 Diabetes MellitusType2 Diabetes

Phase 1

The Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of Evogliptin in Hemodialysis Patients

CompletedNCT04195919

Dong-A ST Co., Ltd.Hemodialysis Patients

Start: 2020-07-10End: 2021-05-24Updated: 2021-12-01

Phase 3

A Clinical Trial to Investigate the Efficacy and Safety of Evogliptin

CompletedNCT02946541

Dong-A ST Co., Ltd.Type 2 Diabetes Mellitus

Start: 2013-07-31End: 2015-04-30Updated: 2017-03-28

Efficacy and Safety of Evogliptin When Added to Ongoing Metformin and Dapagliflozin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control

CompletedNCT04170998

Dong-A ST Co., Ltd.Type2 Diabetes

Start: 2020-01-02End: 2021-12-08Updated: 2021-12-10

Efficacy and Safety of Dapagliflozin When Added to Ongoing Metformin and Evogliptin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control

CompletedNCT04356742

Dong-A ST Co., Ltd.Type 2 Diabetes

Start: 2020-05-26End: 2022-02-23Updated: 2022-03-22

Phase 4

Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Type 2 Diabetes

Seung Up KimDiabetes Mellitus, Type 2, Fibrosis, Liver, Hepatitis B, Chronic

Start: 2020-09-18End: 2023-02-19Updated: 2022-07-26

Related Papers

Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week Extension

Diabetes & Metabolism Journal2023-09-267 citations